Guaifenesin 600 mg
NDC 25000-042, Guaifenesin 600 mg, tablet, from MARKSANS PHARMA LIMITED.
- Product NDC
- 25000-042
- Status
- Listed
- Labeler
- MARKSANS PHARMA LIMITED
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA217780
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25000-042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25000-042-01 | 25000004201 | 1 BOTTLE in 1 CARTON (25000-042-01) / 20 TABLET in 1 BOTTLE |
| 25000-042-12 | 25000004212 | 500 TABLET in 1 BOTTLE (25000-042-12) |
| 25000-042-55 | 25000004255 | 2 BLISTER PACK in 1 CARTON (25000-042-55) / 10 TABLET in 1 BLISTER PACK |
| 25000-042-99 | 25000004299 | 2 BLISTER PACK in 1 CARTON (25000-042-99) / 20 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 25000-042 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25000-042 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25000-042. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.